NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

Clade 1a is the older clade that has been linked to spillovers in animals and some limited human-to-human transmission in ...

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

Feb 13 (Reuters) - Countries outside of Africa are still reporting cases of the clade Ib form of the mpox virus that prompted the World Health Organization to declare the virus a global public ...

The individual who tested positive for mpox clade lb had recently traveled to Africa and is currently under the care of a physician and in isolation, according to state Health Commissioner Dr ...

Photo: Courtesy of Institute of Vertebrate Paleontology and Paleoanthropology (IVPP) of the Chinese Academy of Sciences A new ...

Oil prices declined for a third session on Wednesday, as investors worried about OPEC+ plans to proceed with output increases in April, and U.S. President Donald Trump's tariffs on Canada, China ...

The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...